Hester Biosciences

Update in progress

HESTERBIO.NS (NSE)

Company RatingNeutral
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic

Hester Biosciences Limited develops, manufactures and trades veterinary vaccines and animal health products for India and global markets. It operates in Poultry Healthcare and Animal Healthcare, offering vaccines for Newcastle disease, infectious bronchitis, fowl pox, Marek’s disease and more, plus ruminant vaccines and diagnostics. It provides biosecurity, therapeutics, herbal and homeopathic remedies, feed supplements, pet care, immune and gut-health products, sero-profiling kits and mastitis programs. Established 1987, HQ Mehsana.

Company score

Sentiment: 0.16; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.00; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.16; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.03; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.10; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive